A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors

NCT06239155 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Hepatocellular Carcinoma

Interventions

DRUG: AST-3424

Sponsor

Ascentawits Pharmaceuticals, Ltd